2025. Telmisartan Attenuates Experimental Liver Fibrosis Through Suppression Of Hepatic Stellate Cell Activation And Tgf-Β/Smad Signaling. The Review of Diabetic Studies . (Dec. 2025), 496–510. DOI:https://doi.org/10.70082/y1zx3j95.